Senate HELP Committee votes 15-6 to advance Bertagnolli’s confirmation as NIH director

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several aggressive cuts the White House had proposed for NIH.

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

Over his five decades as a radiation oncologist, Bernie Lewinsky has been collecting the relics of radiotherapy.

NIH ends fetal tissue research—again

NIH will no longer fund scientific research that uses human fetal tissue from elective abortions, a practice that has contributed to the study of cancer, the development of vaccines, and the treatment of other diseases.

NIH agrees to review hundreds of denied or shelved grant applications

Last year, the Trump administration began dismantling, RIFing, and stamping out programs and staff deemed ideological or politically motivated, halting application processes, and stripping funding opportunities.

January 09, 2026

Vol.52 No.1

By Claire Marie Porter

Guest Editorial

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Earlier this month, NCI released a new Cancer Center Support Grant Notice of Funding Opportunity. Except for the elimination of the Plan to Enhance Diversity component and lengthening of the Shared Resource write-ups from three to six pages, the guidelines are essentially unchanged.

December 19, 2025

Vol.51 No.46

By Richard J. Jones

Conversation with The Cancer Letter

Anthony Letai pledges to ensure stability for extramural and intramural cancer science

Stepping into the NCI director’s job at the end of a nerve-racking year, Anthony Letai wants you to know that the federal government is not going out of the business of cancer research.

December 05, 2025

Vol.51 No.44

By Paul Goldberg

Senate HELP Committee votes 15-6 to advance Bertagnolli’s confirmation as NIH director

YOU MAY BE INTERESTED IN

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

NIH ends fetal tissue research—again

NIH agrees to review hundreds of denied or shelved grant applications

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Anthony Letai pledges to ensure stability for extramural and intramural cancer science

Renew today!

Subscriber content

Never miss an issue!

Login

Senate HELP Committee votes 15-6 to advance Bertagnolli’s confirmation as NIH director

YOU MAY BE INTERESTED IN

Spending bill passed by the House gives NIH $415M raise, NCI gets $128MLegislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

NIH ends fetal tissue research—again

NIH agrees to review hundreds of denied or shelved grant applications

With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Anthony Letai pledges to ensure stability for extramural and intramural cancer science

Never miss an issue!

Login

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched